AU2001280673A1 - High-throughput methods for generating and screening compounds that affect cell viability - Google Patents

High-throughput methods for generating and screening compounds that affect cell viability

Info

Publication number
AU2001280673A1
AU2001280673A1 AU2001280673A AU8067301A AU2001280673A1 AU 2001280673 A1 AU2001280673 A1 AU 2001280673A1 AU 2001280673 A AU2001280673 A AU 2001280673A AU 8067301 A AU8067301 A AU 8067301A AU 2001280673 A1 AU2001280673 A1 AU 2001280673A1
Authority
AU
Australia
Prior art keywords
generating
cell viability
screening compounds
affect cell
throughput methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280673A
Inventor
Edward J. Bylina
William J. Coleman
Douglas C. Youvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kairos Scientific Inc
Original Assignee
KAIROS SCIENT Inc
Kairos Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAIROS SCIENT Inc, Kairos Scientific Inc filed Critical KAIROS SCIENT Inc
Publication of AU2001280673A1 publication Critical patent/AU2001280673A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001280673A 2000-07-19 2001-07-19 High-throughput methods for generating and screening compounds that affect cell viability Abandoned AU2001280673A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21917900P 2000-07-19 2000-07-19
US60/219,179 2000-07-19
PCT/US2001/023004 WO2002006517A2 (en) 2000-07-19 2001-07-19 High-throughput methods for generating and screening compounds that affect cell viability

Publications (1)

Publication Number Publication Date
AU2001280673A1 true AU2001280673A1 (en) 2002-01-30

Family

ID=22818195

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280673A Abandoned AU2001280673A1 (en) 2000-07-19 2001-07-19 High-throughput methods for generating and screening compounds that affect cell viability

Country Status (3)

Country Link
US (1) US20020025537A1 (en)
AU (1) AU2001280673A1 (en)
WO (1) WO2002006517A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002361589A1 (en) * 2001-11-06 2003-05-19 Enanta Pharmaceuticals, Inc. Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
US7033769B2 (en) * 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
AU2003269851A1 (en) * 2002-10-09 2004-05-04 Novozymes A/S A method for screening for an antimicrobial polypeptide
US20060134630A1 (en) * 2002-10-09 2006-06-22 Novozymes A/S Method for screening for an antimicrobial polypeptide
US20050052687A1 (en) * 2003-08-12 2005-03-10 Murata Kikai Kabushiki Kaisha Image processing device and communication terminal device
DK1769081T3 (en) * 2004-07-01 2016-03-14 Litron Lab Ltd PROCESS FOR COUNTING OF MAMMALS CELL micronuclei WITH A HEAD WEIGHT OF DIFFERENTIAL STAINING OF micronuclei AND chromatin OF DEAD AND DYING CELLS
US20070231833A1 (en) * 2005-05-23 2007-10-04 Arcidiacono Steven M Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest
US20070042453A1 (en) * 2005-08-22 2007-02-22 Novak John S High throughput screening method for antimicrobial formulations
US20110003702A1 (en) * 2009-06-03 2011-01-06 President And Fellows Of Harvard College Methods, systems, and kits for identification of osteoinductive peptides
CN101307316B (en) * 2008-07-22 2011-03-16 北京中农颖泰生物技术有限公司 Secretion expression of antibiotic peptide CAD in bacillus subtilis and expression system of recombination bacillus subtilis
WO2010129532A2 (en) * 2009-05-05 2010-11-11 Trustees Of Boston University Method and device for rapid detection of bacterial antibiotic resistance/susceptibility
WO2011088401A2 (en) 2010-01-15 2011-07-21 Board Of Regents, The University Of Texas System Development of a high-throughput screen for the identification of novel antifungal drug candidates
CN104011541B (en) 2011-09-13 2016-08-24 国立大学法人大阪大学 The inspection method of the Susceptibility to antibiotics of antibacterial or fungus and the system wherein used
CN103773731A (en) * 2014-01-03 2014-05-07 浙江大学宁波理工学院 Method for improving apparent catalytic activity of glutamic acid decarboxylase recombinant engineering bacteria
US20150247792A1 (en) * 2014-03-03 2015-09-03 University Of Notre Dame Systems and methods for cancer cell detection
US11236138B2 (en) * 2020-01-14 2022-02-01 Renorigin Innovation Institute Co., Ltd. Peptide, method and composition for melanin polymerization and hair darkening
EP4310192A1 (en) * 2022-07-21 2024-01-24 C4Diagnostics Method of determining the existence and/or degree of resistance of microorganisms to antimicrobial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620923A (en) * 1989-10-12 1997-04-15 The University Of Utah Synthesis of peptides as cloned ubiquitin extensions
AU3363399A (en) * 1998-03-27 1999-10-18 President And Fellows Of Harvard College Aptamer based bacterial inhibition systems (abbis)

Also Published As

Publication number Publication date
US20020025537A1 (en) 2002-02-28
WO2002006517A3 (en) 2002-09-19
WO2002006517A2 (en) 2002-01-24
WO2002006517A9 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2001280673A1 (en) High-throughput methods for generating and screening compounds that affect cell viability
SG115519A1 (en) Methods, instruments and materials for chondrocyte cell transplantation
AU2001288750A1 (en) Particle or cell analyzer and method
AU2001236177A1 (en) T cell receptor libraries
AU2001244625A1 (en) Cell culturing method and device
AU2002230527A1 (en) Mailer for cell culture apparatus
AU2002303343A1 (en) Methods and reagents for cell transplantation
AU2001263162A1 (en) Microfluidics devices and methods for high throughput screening
AU7867600A (en) Methods and apparatus for cell analysis
AU2003211005A1 (en) Compositions comprising reproductive cell media and methods for using such compositions
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2001245479A1 (en) Solid phase enzyme kinetics screening in microcolonies
AU2001275007A1 (en) Methods of testing materials
AU2002235728A1 (en) Method for generating insulin-secreting cells suitable for transplantation
AU2001294342A1 (en) Porous attachment material for cells
AU2001268077A1 (en) High efficiency cell analysis system and high throughput drug screening system
AU2003261353A1 (en) High density reagent array preparation methods
AU2003226655A1 (en) Acoustical cell for material analysis
AU2001290855A1 (en) Method and cell composition for screening compounds for anti-inflammatory activity
AU2002335663A1 (en) Methods and devices for detecting cell-cell interactions
AU2003300492A1 (en) Sample cell
AU2002305092A1 (en) Method and system for high-throughput screening
GB0126495D0 (en) Support and method for cell based assays
AU2003265268A1 (en) Methods and compositions for screening cell binding molecules
AU2002351241A1 (en) Methods and apparatus for cell based screening